Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Michael T, Dellinger"'
Autor:
Michael T. Dellinger, Tiffany Ferry, David Williams, Tracy Milne, Louise Murgia, Michael Kelly
Publikováno v:
Journal of Vascular Anomalies, Vol 5, Iss 2, p e085 (2024)
Objectives:. Complex lymphatic anomalies (CLAs) are rare diseases with variable clinical manifestations caused by the abnormal development of lymphatic vessels. The Lymphatic Malformation Institute (LMI), Lymphangiomatosis & Gorham’s Disease Allian
Externí odkaz:
https://doaj.org/article/137975c3d167419d8f39c58a234f2111
Autor:
Anna L. McCarter, Michael T. Dellinger
Publikováno v:
Journal of Vascular Anomalies, Vol 4, Iss 4, p e070 (2023)
Objective:. Gorham-Stout disease (GSD) is a rare lymphatic anomaly that can be caused by somatic activating mutations in KRAS. This discovery has led investigators to suggest that MEK inhibitors could be a novel treatment for GSD. However, the effect
Externí odkaz:
https://doaj.org/article/628977654a84472b8067c0b9c3330262
Autor:
Lorenzo M. Fernandes, Jeffrey Tresemer, Jing Zhang, Jonathan J. Rios, Joshua P. Scallan, Michael T. Dellinger
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Complex lymphatic anomalies (CLAs) are sporadically occurring diseases caused by the maldevelopment of lymphatic vessels. We and others recently reported that somatic activating mutations in KRAS can cause CLAs. However, the mechanisms by which activ
Externí odkaz:
https://doaj.org/article/ba2b069fed614929b94de62055977d42
Autor:
Nassim Homayun-Sepehr, Anna L. McCarter, Raphaël Helaers, Christine Galant, Laurence M. Boon, Pascal Brouillard, Miikka Vikkula, Michael T. Dellinger
Publikováno v:
JCI Insight, Vol 6, Iss 15 (2021)
Gorham-Stout disease (GSD) is a sporadically occurring lymphatic disorder. Patients with GSD develop ectopic lymphatics in bone, gradually lose bone, and can have life-threatening complications, such as chylothorax. The etiology of GSD is poorly unde
Externí odkaz:
https://doaj.org/article/daf96aceec344bbdab8af7aa33bd468c
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 10, Pp 1-3 (2020)
Abstract Sporadic lymphatic diseases are orphans among orphans in the medical community, a diverse collection of disorders at the intersection of cardiac, gastrointestinal, pulmonary, dermatologic, and oncologic disease that receives only passing att
Externí odkaz:
https://doaj.org/article/5f8356fd1eee46688c5f887a7456ceac
Autor:
Pier Paolo Scaglioni, Julie Teruya-Feldstein, Adriana Heguy, Ignacio I. Wistuba, Rolf A. Brekken, Michael T. Dellinger, Carmen Behrens, Yiran Cai, Rachel E. Ramirez, Kim Kangasniemi, Francesca Torti, Giorgio Ramadori, Georgia Konstantinidou
Supplementary Figure 2 PDF file - 182K, This Figure shows the activation status of RhoA and Rac1 in mouse lungs and validation of RhoA-GTP antibody on mouse lung tissue by IHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38687d1b8d1b31a0f4850ae7ef43e5f4
https://doi.org/10.1158/2159-8290.22530468.v1
https://doi.org/10.1158/2159-8290.22530468.v1
Autor:
Pier Paolo Scaglioni, Julie Teruya-Feldstein, Adriana Heguy, Ignacio I. Wistuba, Rolf A. Brekken, Michael T. Dellinger, Carmen Behrens, Yiran Cai, Rachel E. Ramirez, Kim Kangasniemi, Francesca Torti, Giorgio Ramadori, Georgia Konstantinidou
Supplementary Figure 6 PDF file - 141K, This Figure shows that FAK is co-expressed with RHOA in lung adenocarcinomas. In addition, we provide the validation of RHOA-GTP antibody on human specimens by IHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7117ffbaeeb21e74b4ed1f78d0475db
https://doi.org/10.1158/2159-8290.22530456
https://doi.org/10.1158/2159-8290.22530456
Autor:
Nick Loizos, Rolf A. Brekken, Colleen Burns, Timothy Bailey, Jennifer Malaby, Inga Duignan, Michael Peyton, Jason E. Toombs, Michael T. Dellinger, Puja Gupta, David E. Gerber
PDF file, 156K, Species and target specificity of IMC-3G3 and 1E10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433fb0e5b3f734405f2853cb0aa6d4da
https://doi.org/10.1158/1535-7163.22497432
https://doi.org/10.1158/1535-7163.22497432
Autor:
Pier Paolo Scaglioni, Julie Teruya-Feldstein, Adriana Heguy, Ignacio I. Wistuba, Rolf A. Brekken, Michael T. Dellinger, Carmen Behrens, Yiran Cai, Rachel E. Ramirez, Kim Kangasniemi, Francesca Torti, Giorgio Ramadori, Georgia Konstantinidou
Supplementary Figure 1 PDF file - 311K, This Figure shows that the KrasG12D;Ink4a/Arf -/- mice show increased tumor burden, increased Ki-67, Cyclin D1 expression and decreased survival compared to KrasG12D;Ink4a/Arf +/+ mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9088e0adb9fc50574b321fc0f0e199fb
https://doi.org/10.1158/2159-8290.22530471.v1
https://doi.org/10.1158/2159-8290.22530471.v1
Autor:
Pier Paolo Scaglioni, Julie Teruya-Feldstein, Adriana Heguy, Ignacio I. Wistuba, Rolf A. Brekken, Michael T. Dellinger, Carmen Behrens, Yiran Cai, Rachel E. Ramirez, Kim Kangasniemi, Francesca Torti, Giorgio Ramadori, Georgia Konstantinidou
Supplementary Figure 7 PDF file - 205K, This Figure shows that pharmacological inhibition of FAK results in suppression of NSCLC in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0275b918eff4e3b79a45c8f915a4bb19
https://doi.org/10.1158/2159-8290.22530453
https://doi.org/10.1158/2159-8290.22530453